Dichain Structure of Botulinum Neurotoxin: Identification of Cleavage Sites in Types C, D, and F Neurotoxin Molecules

被引:0
|
作者
Yoshimasa Sagane
Toshihiro Watanabe
Hirokazu Kouguchi
Hiroyuki Sunagawa
Kaoru Inoue
Yukako Fujinaga
Keiji Oguma
Tohru Ohyama
机构
[1] Tokyo University of Agriculture,Department of Food Science, Faculty of Bioindustry
[2] Hokkaido Institute of Public Health,Department of Bacteriology
[3] Okayama University Medical School,undefined
来源
关键词
Botulinum neurotoxin; N-terminal amino acid sequence; C-terminal amino acid sequence; surface probability;
D O I
暂无
中图分类号
学科分类号
摘要
Botulinum neurotoxin (NT) is synthesized by Clostridium botulinum as about a 150-kDa single-chain polypeptide. Posttranslational modification by bacterial or exogenous proteases yielded dichain structure which formed a disulfide loop connecting a 50-kDa light chain (Lc) and 100-kDa heavy chain (Hc). We determined amino acid sequences around cleavage sites in the loop region of botulinum NTs produced by type C strain Stockholm, type D strain CB16, and type F strain Oslo by analysis of the C-terminal sequence of Lc and the N-terminal sequence of Hc. Cleavage was found at one or two sites at Arg444/Ser445 and Lys449/Thr450 for type C, and Lys442/Asn443 and Arg445/Asp446 for type D, respectively. In culture fluid of mildly proteolytic strains of type C and D, therefore, NT exists as a mixture of at least three forms of nicked dichain molecules. The NT of type F proteolytic strain Oslo showed the Arg435 as a C-terminal residue of Lc and Ala440 as an N-terminal residue of Hc, indicating that the bacterial protease cuts twice (Arg435/Lys436 and Lys439/Ala440), with excision of four amino acid residues. The location of cleavage and number of amino acid residue excisions in the loop region could be explained by the degree of exposure of amino acid residues on the surface of the molecule, which was predicted as surface probability from the amino acid sequence. In addition, the observed correlation may also be adapted to the cleavage sites of the other botulinum toxin types, A, B, E, and G.
引用
收藏
页码:885 / 892
页数:7
相关论文
共 50 条
  • [31] Identification and characterization of a neutralizing monoclonal antibody against botulinum neurotoxin, serotype F, following vaccination with active toxin
    Brown, DR
    Lloyd, JP
    Schmidt, JJ
    HYBRIDOMA, 1997, 16 (05): : 447 - 456
  • [32] Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricumtype E strains
    Karen K Hill
    Gary Xie
    Brian T Foley
    Theresa J Smith
    Amy C Munk
    David Bruce
    Leonard A Smith
    Thomas S Brettin
    John C Detter
    BMC Biology, 7
  • [33] Identification of type A, B, E, and F botulinum neurotoxin genes and of botulinum neurotoxigenic clostridia by denaturing high-performance liquid chromatography
    Franciosa, G
    Pourshaban, M
    De Luca, A
    Buccino, A
    Dallapiccola, B
    Aureli, P
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2004, 70 (07) : 4170 - 4176
  • [34] A Four-Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotypes C and D
    Garcia-Rodriguez, Consuelo
    Yan, Shude
    Geren, Isin N.
    Knopp, Kristeene A.
    Dong, Jianbo
    Sun, Zhengda
    Lou, Jianlong
    Conrad, Fraser
    Wen, Wei-Hua
    Farr-Jones, Shauna
    Smith, Theresa J.
    Brown, Jennifer L.
    Skerry, Janet C.
    Smith, Leonard A.
    Marks, James D.
    TOXINS, 2021, 13 (09)
  • [35] Botulinum neurotoxin type A: Limited proteolysis by endoproteinase Glu-C and alpha-chymotrypsin enhanced following reduction; Identification of the cleaved sites and fragments
    Beecher, DJ
    DasGupta, BR
    JOURNAL OF PROTEIN CHEMISTRY, 1997, 16 (07): : 701 - 712
  • [36] Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains
    Hill, Karen K.
    Xie, Gary
    Foley, Brian T.
    Smith, Theresa J.
    Munk, Amy C.
    Bruce, David
    Smith, Leonard A.
    Brettin, Thomas S.
    Detter, John C.
    BMC BIOLOGY, 2009, 7 : 66
  • [37] Potency and stability of a trivalent, catalytically inactive vaccine against botulinum neurotoxin serotypes C, E and F (triCEF)
    Webb, Robert
    Wright, Patrick M.
    Brown, Jennifer L.
    Skerry, Janet C.
    Guernieri, Rebecca L.
    Smith, Theresa J.
    Stawicki, Christopher
    Smith, Leonard A.
    TOXICON, 2020, 176 : 67 - 76
  • [38] Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E:: Domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage
    Vaidyanathan, VV
    Yoshino, K
    Jahnz, M
    Dörries, C
    Bade, S
    Nauenburg, S
    Niemann, H
    Binz, T
    JOURNAL OF NEUROCHEMISTRY, 1999, 72 (01) : 327 - 337
  • [39] Quantitative real-time PCR for detection of neurotoxin genes of Clostridium botulinum types A, B and C in equine samples
    Johnson, Amy L.
    McAdams-Gallagher, Susan C.
    Sweeney, Raymond W.
    VETERINARY JOURNAL, 2014, 199 (01): : 157 - 161
  • [40] Sensitive and Accurate Detection of Botulinum Neurotoxin Types A, B, E, and F From Diverse Food Samples Using the BoLISA® Assay
    Dunning, F. Mark
    Piazza, Timothy M.
    Tucker, Ward C.
    TOXICON, 2024, 237 : 23 - 23